January 2005
Taber's Cyclopedic Medical Dictionary;2005, p1788
Reference Entry
A definition of the term "prostate" is presented. It is a gland that surrounds the neck of the bladder and the urethra in the male. It consists of a median lobe and two lateral lobes and is partly muscular and partly glandular. It weighs about twenty grams and is enclosed in a fibrous capsule containing smooth muscle fibres in its inner layer.


Related Articles

  • prostatic.  // Taber's Cyclopedic Medical Dictionary;2005, p1790 

    A definition to the term "prostatic" is presented. The term is used to refer to matters concerning the prostate gland.

  • prostato-, prostat–.  // Taber's Cyclopedic Medical Dictionary;2005, p1790 

    A definition of two terms "prostato-" and "prostat" are presented. These two terms are combining forms that mean prostate gland.

  • prostatalgia.  // Taber's Cyclopedic Medical Dictionary;2005, p1788 

    A definition of the term "prostatalgia" is presented. The term refers to a condition in which a person experiences pain in the prostate glands. The condition is also referred to as prostatodynia.

  • The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Wayne A. Fritz; Tien-Min Lin; Robert D. Cardiff; Richard E. Peterson // Carcinogenesis;Feb2007, Vol. 28 Issue 2, p497 

    The aryl hydrocarbon receptor (AhR) is a transcription factor that mediates the inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on prostate growth and also modulates normal prostate development. This is evidenced by AhR null mice (Ahr−/−) having smaller dorsolateral...

  • Chemoprevention of rat prostate carcinogenesis by dietary 16α-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone. David L. McCormick; William D. Johnson; Nicole M. Kozub; K.V.N. Rao; Ronald A. Lubet; Vernon E. Steele; Maarten C. Bosland // Carcinogenesis;Feb2007, Vol. 28 Issue 2, p398 

    Dehydroepiandrosterone (DHEA) is a potent inhibitor of prostate carcinogenesis in rats. However, concerns related to the possible androgenicity of DHEA may preclude its use for chemoprevention of human prostate cancer. Studies were performed to compare the androgenicity of DHEA and a fluorinated...

  • Androgen Deprivation Therapy for Localized Prostate Cancer. Kuritzky, Louis // OB/GYN Clinical Alert;Sep2008 Clinical Briefs in Primary, Vol. 13 Issue 9, p18 

    The article presents a study on the evaluation data on men treated with either androgen deprivation therapy (ADT) or conservative management for prostate cancer in the U.S. Study shows that ADT did not show advantage compared to conservative management for either mortality specifically related...

  • Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self. Cam, K.; Akman, Y.; Cicekci, B.; Senel, F.; Erol, A. // Prostate Cancer & Prostatic Diseases;2004, Vol. 7 Issue 1, p41 

    International prostate symptom score (IPSS) was claimed to be complicated for patients. The aim of this study was to measure differences in IPSS when introduced by a physician vs self-administration. Patients with lower urinary tract symptoms completed two IPSS questionnaires: one...

  • prostatomy, prostatotomy.  // Taber's Cyclopedic Medical Dictionary;2005, p1791 

    A definition of the term "prostatomy" is presented. It refers to the surgery of the prostate gland.

  • prostatorrhea.  // Taber's Cyclopedic Medical Dictionary;2005, p1791 

    A definition of the term "prostatorrhea" is presented. It refers to an unusual discharge from the prostate gland.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics